Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor-Reference-Cited by-同舟云学术

Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor

Published:2023-10-27 Issue:12 Volume:43 Page:1386-1390
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Ivanisevic Tonci¹,Steklov Mikhail¹,Lechat Benoit¹,Cawthorne Christopher²,Gsell Willy³,Velde Greetje Vande³,Deroose Christophe²,Van Laere Koen²,Himmelreich Uwe³,Sewduth Raj N¹,Sablina Anna A¹^ORCID

Affiliation:

1. VIB‐KU Leuven Center for Cancer Biology VIB Leuven Belgium

2. Nuclear Medicine and Molecular Imaging Department of Imaging and Pathology KU Leuven Leuven Belgium

3. Biomedical MRI Department of Imaging and Pathology KU Leuven Leuven Belgium

Funder

H2020 European Research Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12490

Reference10 articles.

1. Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination

2. LZTR1Mutation Mediates Oncogenesis through Stabilization of EGFR and AXL

3. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis

4. Schwannoma development is mediated by Hippo pathway dysregulation and modified by RAS/MAPK signaling

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased dosage of wild-type KRAS protein drivesKRAS-mutant lung tumorigenesis and drug resistance;2024-03-01

2. Relevance of Carcinogen-Induced Preclinical Cancer Models;Journal of Xenobiotics;2024-01-05